Skip to main content
Clinical Trials/CTRI/2023/04/051559
CTRI/2023/04/051559
Not yet recruiting
未知

Motivational Enhancement Therapy to Reduce Adverse TreatmentOutcomes (Default, Death and Failure)among TB Patients having Alcohol Abuseunder Programmatic Settings: a randomized control trial.

ICMR-National JALMA Institute for Leprosy and Other Mycobacterial Diseases0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
ICMR-National JALMA Institute for Leprosy and Other Mycobacterial Diseases
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
ICMR-National JALMA Institute for Leprosy and Other Mycobacterial Diseases

Eligibility Criteria

Inclusion Criteria

  • NewTB patients having addiction of alcohol
  • Patients ready to give informedwrittenconsent

Exclusion Criteria

  • New TB patients not having addiction of alcohol
  • TB Patients not ready to give informed written consent
  • TB patients less than 14/18 years of age i.e. pediatric age group will be
  • TB patients more than 65 years of age i.e. geriatric age group will be excluded.
  • TB patients having pre\-identified complaints relating to mental retardation or
  • any other severe psychopathology.
  • TB patients having head injury or any severe neurological problem.
  • Multi\-Drug Resistant TB patients
  • Pregnant women who have TB will be excluded.
  • Patients who do not take the full course of (12 sessions) of MET therapy would be excluded from the final analysis

Outcomes

Primary Outcomes

Not specified

Similar Trials